APA

Miller K. D., O'Neill A., Perez E. A., Seidman A. D. & Sledge G. W. (20120522). A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Miller K D, O'Neill A, Perez E A, Seidman A D and Sledge G W. 20120522. A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Miller K. D., O'Neill A., Perez E. A., Seidman A. D. and Sledge G. W. (20120522). A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Miller K D, O'Neill A, Perez E A, Seidman A D and Sledge G W. A phase II pilot trial incorporating bevacizumab into dose-dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: a trial coordinated by the Eastern Cooperative Oncology Group. : Annals of oncology : official journal of the European Society for Medical Oncology. 20120522.